Condition
Myasthenia Gravis, Generalized clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Myasthenia Gravis, Generalized clinical trials that are recruiting, at sites in 10 countries (most in United States (6), Italy (3), France (2)). By phase: Phase 3 (1), Phase 4 (1), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 10Countries
Newest Myasthenia Gravis, Generalized clinical trials
All recruiting trials (12)
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
MG patient registry to track long-term experiences and treatment patterns
This registry collects information from adults with myasthenia gravis to see how symptoms and quality of life change over time and how treatments relate to those changes.
-
Panorama: Neuromuscular Organoids to understand refractory AChR+ myasthenia gravis
This study tests neuromuscular organoids built from stem cells to see if they reveal why some people with AChR-positive myasthenia gravis don’t respond to standard treatments.
-
Claseprubart in adults with generalized myasthenia gravis
This study tests whether claseprubart can help adults with generalized myasthenia gravis when compared with placebo.
-
Aritinercept for generalized myasthenia gravis
This study tests whether aritinercept is safe and helpful for adults with generalized myasthenia gravis compared with placebo.
-
MyoSense 360 in generalized myasthenia gravis: testing digital monitoring to track change
This study tests whether a digital monitoring system can detect meaningful changes in generalized myasthenia gravis over a year in adult patients using a smartphone app and wearable device.
-
Corticosteroid-sparing efgartigimod for elderly AChR-positive generalized myasthenia gravis
This trial tests whether efgartigimod given IV or under the skin helps people 65 and older with AChR-positive generalized myasthenia gravis reduce their corticosteroid dose while keeping symptoms under control.
-
Observational study on ravulizumab for generalized myasthenia gravis
This study is looking at how well ravulizumab works for people with generalized myasthenia gravis over three years to see how it helps their health.
-
Registry for people living with Myasthenia Gravis
This study is collecting information from people with Myasthenia Gravis to understand their experiences, symptoms, and treatments over time.
-
Identifying markers for effective treatment of Myasthenia Gravis with complement inhibitors
This study is trying to find out which markers can help doctors know if complement inhibitor therapy will work well for people with generalized Myasthenia Gravis who have anti-AChR antibodies.
-
Using Tocilizumab to treat Generalized Myasthenia Gravis
This study is testing if Tocilizumab can help people with Generalized Myasthenia Gravis who have anti-AChR antibodies feel better and improve their symptoms.
-
A platform for collecting health data on ME/CFS and Long Covid
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
Related topics
Quick answers
How many Myasthenia Gravis, Generalized clinical trials are recruiting right now?
12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (6 trials), Italy (3 trials), France (2 trials), Denmark (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 4: 1, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.